AstraZeneca’s Tagrisso helps lung cancer patients live longer- study (Aug. 9)

Reuters Aug 9 (Reuters) – AstraZeneca Plc said on Friday a late-stage study showed its top-selling drug, Tagrisso, had significantly helped patients with a type of lung cancer live longer. The British drugmaker announced overall positive survival results from the study in patients with epidermal growth factor receptor-mutated metastatic […]

Leave a Reply